Paul A. Wagner Ph.D.
Net Worth

Last updated:

What is Paul A. Wagner Ph.D. net worth?

The estimated net worth of Dr. Paul A. Wagner Ph.D. is at least $29,654,623 as of 1 Oct 2024. He owns shares worth $21,423,023 as insider, has earned $4,347,000 from insider trading and has received compensation worth at least $3,884,600 in Forte Biosciences, Inc..

What is the salary of Paul A. Wagner Ph.D.?

Dr. Paul A. Wagner Ph.D. salary is $776,920 per year as Pres, Chief Executive Officer & Chairman in Forte Biosciences, Inc..

How old is Paul A. Wagner Ph.D.?

Dr. Paul A. Wagner Ph.D. is 55 years old, born in 1970.

What stocks does Paul A. Wagner Ph.D. currently own?

As insider, Dr. Paul A. Wagner Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Forte Biosciences, Inc. (FBRX) Pres, Chief Executive Officer & Chairman 1,823,236 $11.75 $21,423,023

What does Forte Biosciences, Inc. do?

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

FBRX logo
FBRX
Forte Biosciences, Inc.
$11.75

Paul A. Wagner Ph.D. insider trading

Forte Biosciences, Inc.

Dr. Paul A. Wagner Ph.D. has made only one insider trade between 2020-2024, according to the Form 4 filled with the SEC.

As of 1 Oct 2024 he still owns at least 1,823,236 units of FBRX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,250 N/A N/A
Option
Restricted Stock Units 1,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Purchase
Common Stock 10,000 $0.75 $7,530
Purchase
Common Stock 10,000 $0.72 $7,200
Purchase
Common Stock 10,520 $0.7 $7,353
Purchase
Common Stock 4,776 $0.65 $3,090
Purchase
Common Stock 25,000 $0.65 $16,200
Purchase
Common Stock 15,000 $0.62 $9,300
Purchase
Common Stock 36,203 $0.59 $21,179
Purchase
Common Stock 400 $0.43 $172
Purchase
Common Stock 1,566 $0.43 $673
Purchase
Common Stock 5,300 $0.44 $2,332
Purchase
Common Stock 100 $0.43 $43
Option
Restricted Stock Units 31,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Option
Restricted Stock Units 31,250 N/A N/A
Option
Common Stock 31,250 N/A N/A
Purchase
Common Stock 44,024 $1.07 $47,018
Purchase
Common Stock 55,976 $1.03 $57,655
Sale
Common Stock 1,000,000 $4.35 $4,347,000
Purchase
Common Stock 7,000 $14.48 $101,353

Forte Biosciences key executives

Forte Biosciences, Inc. executives and other stock owners filed with the SEC:

  • Dr. Paul A. Wagner Ph.D. (55) Pres, Chief Executive Officer & Chairman
  • Mr. Antony A. Riley CPA (58) Chief Financial Officer